SCHEMBL19080078

SCHEMBL19080078

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5cc6oc7ccc8ccccc8c7c6c6ccccc56)c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.39
CYP1A1 P04798 3/20 0.39
AHR P35869 3/20 0.39
PAX8 Q06710 2/20 0.39
CYP1A2 P05177 2/20 0.39
FYN P06241 1/20 0.39
MAPK3 P27361 1/20 0.39
NPC1 O15118 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
RAB9A P51151 1/20 0.39
CYP1B1 Q16678 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127333 0.93 ABCG2 (0.41) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL19076469 0.92 TDP1 (0.35) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL20127738 0.92 ABCG2 (0.40) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL20127736 0.90 ABCG2 (0.40) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL19080094 0.90 ABCG2 (0.41) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL19080015 0.89 ABCG2 (0.47) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL19079983 0.89 ABCG2 (0.40) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL20127341 0.88 ABCG2 (0.41) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL19080080 0.88 GPR84 (0.35) ABCG2CYP1A1PAX8CYP1A2NPC1
SCHEMBL19080064 0.88 ABCG2 (0.38) ABCG2CYP1A1AHRPAX8CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ABCG2 4758/4885CYP1A1 147/4885AHR 2211/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ABCG2 4758/4885CYP1A1 147/4885AHR 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.